Birdwatch Note
2023-11-06 16:28:08 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Não existe evidência científica robusta de benefício para qualquer tipo de rastreio de câncer de próstata para homens de baixo risco. O INCA (instituto nacional do câncer) e outras associações médicas se posicionam contra a medida. Pode ser até mesmo maléfica. https://www.inca.gov.br/publicacoes/notas-tecnicas/rastreamento-do-cancer-de-prostata
Written by 6F32871A2544F96461786FBA2CC14658161C326274166F430DE3490F4C7BBBFA
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1721531632484761888
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1721565137780240727
- noteId - 1721565137780240727
- participantId -
- noteAuthorParticipantId - 6F32871A2544F96461786FBA2CC14658161C326274166F430DE3490F4C7BBBFA Participant Details
- createdAtMillis - 1699288088635
- tweetId - 1721531632484761888
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Não existe evidência científica robusta de benefício para qualquer tipo de rastreio de câncer de próstata para homens de baixo risco. O INCA (instituto nacional do câncer) e outras associações médicas se posicionam contra a medida. Pode ser até mesmo maléfica. https://www.inca.gov.br/publicacoes/notas-tecnicas/rastreamento-do-cancer-de-prostata
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-11-06 16:28:08 UTC (1699288088635) |
1969-12-31 23:59:59 UTC (-1) |
2023-11-07 03:05:44 UTC (1699326344811) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-11-06 18:23:37 -0600 | Rating Details | |
| 2023-11-06 18:22:10 -0600 | Rating Details | |
| 2023-11-06 18:19:34 -0600 | Rating Details | |
| 2023-11-06 18:17:40 -0600 | Rating Details | |
| 2023-11-06 17:50:41 -0600 | Rating Details | |
| 2023-11-06 17:43:53 -0600 | Rating Details | |
| 2023-11-06 17:31:36 -0600 | Rating Details | |
| 2023-11-06 17:16:03 -0600 | Rating Details | |
| 2023-11-06 17:09:02 -0600 | Rating Details | |
| 2023-11-06 17:03:35 -0600 | Rating Details | |
| 2023-11-06 16:49:12 -0600 | Rating Details | |
| 2023-11-06 16:49:10 -0600 | Rating Details | |
| 2023-11-06 16:35:15 -0600 | Rating Details | |
| 2023-11-06 16:32:32 -0600 | Rating Details | |
| 2023-11-06 16:29:09 -0600 | Rating Details | |
| 2023-11-06 16:08:28 -0600 | Rating Details | |
| 2023-11-06 15:44:42 -0600 | Rating Details | |
| 2023-11-06 15:26:14 -0600 | Rating Details | |
| 2023-11-06 15:02:50 -0600 | Rating Details | |
| 2023-11-06 15:01:13 -0600 | Rating Details | |
| 2023-11-06 14:55:56 -0600 | Rating Details | |
| 2023-11-06 14:45:36 -0600 | Rating Details | |
| 2023-11-06 14:39:08 -0600 | Rating Details | |
| 2023-11-06 14:13:32 -0600 | Rating Details | |
| 2023-11-06 13:48:30 -0600 | Rating Details | |
| 2023-11-06 13:42:12 -0600 | Rating Details | |
| 2023-11-06 13:27:23 -0600 | Rating Details | |
| 2023-11-06 13:22:38 -0600 | Rating Details | |
| 2023-11-06 13:09:25 -0600 | Rating Details | |
| 2023-11-06 13:08:51 -0600 | Rating Details | |
| 2023-11-06 12:55:30 -0600 | Rating Details | |
| 2023-11-06 12:51:40 -0600 | Rating Details | |
| 2023-11-06 12:43:01 -0600 | Rating Details | |
| 2023-11-06 12:34:21 -0600 | Rating Details | |
| 2023-11-06 12:17:03 -0600 | Rating Details | |
| 2023-11-06 12:11:18 -0600 | Rating Details | |
| 2023-11-06 11:48:06 -0600 | Rating Details | |
| 2023-11-06 11:45:48 -0600 | Rating Details | |
| 2023-11-06 11:41:52 -0600 | Rating Details | |
| 2023-11-06 11:40:37 -0600 | Rating Details | |
| 2023-11-06 11:32:14 -0600 | Rating Details | |
| 2023-11-06 11:29:02 -0600 | Rating Details | |
| 2023-11-06 11:27:24 -0600 | Rating Details | |
| 2023-11-06 11:19:04 -0600 | Rating Details | |
| 2023-11-06 11:04:12 -0600 | Rating Details | |
| 2023-11-06 11:03:50 -0600 | Rating Details | |
| 2023-11-06 11:02:59 -0600 | Rating Details | |
| 2023-11-06 10:55:31 -0600 | Rating Details | |
| 2023-11-06 10:54:49 -0600 | Rating Details | |
| 2023-11-06 10:52:45 -0600 | Rating Details | |
| 2023-11-06 10:49:22 -0600 | Rating Details | |
| 2023-11-06 10:39:09 -0600 | Rating Details | |
| 2023-11-07 10:32:34 -0600 | Rating Details | |
| 2023-11-07 09:09:47 -0600 | Rating Details | |
| 2023-11-07 06:49:14 -0600 | Rating Details | |
| 2023-11-07 06:44:07 -0600 | Rating Details | |
| 2023-11-07 03:51:41 -0600 | Rating Details | |
| 2023-11-07 00:36:28 -0600 | Rating Details | |
| 2023-11-07 00:35:25 -0600 | Rating Details | |
| 2023-11-06 22:09:15 -0600 | Rating Details | |
| 2023-11-06 21:16:14 -0600 | Rating Details | |
| 2023-11-06 21:02:55 -0600 | Rating Details | |
| 2023-11-07 19:09:41 -0600 | Rating Details | |
| 2023-11-15 13:14:36 -0600 | Rating Details |